UniQure pulls first EU gene therapy – PMLiVE
|
UniQure pulls first EU gene therapy
PMLiVE Dutch biotech UniQure made headlines in 2012 when it won approval for its Glybera gene therapy, which at more than €1m is the world's most expensive drug. Now just five years later, it is pulling it off the market. UniQure said there was simply not … |
